Literature DB >> 18631162

Anti-A and anti-B titers in pooled group O platelets are comparable to apheresis platelets.

Laura L Cooling1, Theresa A Downs, Suzanne H Butch, Robertson D Davenport.   

Abstract

BACKGROUND: Although uncommon, acute hemolytic transfusion reactions (AHTRs) have been reported after transfusion of group O single-donor apheresis platelets (SDPs) to group A, B, and AB recipients. Current methods for identifying "high-titer" SDPs include tube and gel methods. The risk of a high-titer unit is considered low with group O, poststorage, pooled platelet concentrates (PPLTs); however, data regarding anti-A and anti-B titers in PPLTs are lacking. STUDY DESIGN AND METHODS: Anti-A and anti-B titers were determined in 185 PPLTs by direct agglutination using manual gel and tube methods. PPLTs tested included 124 group O PPLTs, 25 group A PPLTs, 26 group B PPLTs, and 10 PPLTs containing a mix of either groups O plus A or groups O plus B (mixed PPLTs). The reciprocal of the highest dilution giving macroscopic agglutination was considered the agglutinin titer.
RESULTS: Mean anti-A and anti-B titers in group O PPLTs were, respectively, 16 and 8 by tube and 64 and 32 by gel (p < 0.0001). Gel titers were one to two dilutions higher than tube and sensitive to reagent red cell lots. With the use of at least 64 as a critical titer, 60 percent of group O PPLTs tested by gel would be considered high-titer. In mixed PPLTs, the addition of one non-group O PLT significantly decreased or neutralized the corresponding anti-A or anti-B (p < 0.0001).
CONCLUSION: Anti-A and anti-B titers in group O PPLTs are comparable to those reported in group O SDPs and significantly lower than titers reported in AHTR. A critical direct agglutinin titer of 64 for identifying high-titer units by gel is too low and should be increased to 128 or higher.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18631162     DOI: 10.1111/j.1537-2995.2008.01814.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

1.  Platelet transfusion - the art and science of compromise.

Authors:  Joan Cid; Sarah K Harm; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2013-04-26       Impact factor: 3.747

2.  Effectiveness of Pooled Platelet Transfusion in Concordant and Discordant Groups among Dengue Patients.

Authors:  Amoolya Bhat; Vijaya Chowdappa; Smita Surendra Masamatti
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.

Authors:  Karen Quillen; Sherry L Sheldon; Jennifer A Daniel-Johnson; A Hallie Lee-Stroka; Willy A Flegel
Journal:  Transfusion       Date:  2011-01       Impact factor: 3.157

4.  Potential impact of complement regulator deficiencies on hemolytic reactions due to minor ABO-mismatched transfusions.

Authors:  Priyanka Pandey; Waseem Q Anani; Jerome L Gottschall; Gregory A Denomme
Journal:  Blood Adv       Date:  2017-10-11

5.  ABO-incompatible platelets are associated with increased transfusion reaction rates.

Authors:  Natalie Malvik; Judith Leon; Annette J Schlueter; Chaorong Wu; C Michael Knudson
Journal:  Transfusion       Date:  2020-01-08       Impact factor: 3.157

6.  ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.

Authors:  Matthew S Karafin; Lorraine Blagg; Aaron A R Tobian; Karen E King; Paul M Ness; William J Savage
Journal:  Transfusion       Date:  2012-02-17       Impact factor: 3.157

7.  Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.

Authors:  Jennifer Daniel-Johnson; Susan Leitman; Harvey Klein; Harvey Alter; Agnes Lee-Stroka; Phillip Scheinberg; Jeremy Pantin; Karen Quillen
Journal:  Transfusion       Date:  2009-05-11       Impact factor: 3.157

8.  Quality improvement with platelet additive solution for safer out-of-group platelet transfusions.

Authors:  Maxim Tynuv; Willy A Flegel
Journal:  Immunohematology       Date:  2019-09

9.  ABO isohemagglutinin titration or hemolysin test: what should we do to reduce the risk of passive hemolysis?

Authors:  Lilian Castilho
Journal:  Rev Bras Hematol Hemoter       Date:  2015-05-18

10.  Titers of ABO antibodies in group O blood donors.

Authors:  Natalia Dallaval Galvão de França; Mônica Caamaño Cristovão Poli; Patrícia Guilhem de Almeida Ramos; Cláudia Strang da Rocha Borsoi; Rafael Colella
Journal:  Rev Bras Hematol Hemoter       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.